Holding(s) in Company

RNS Number : 7040C
e-Therapeutics plc
10 March 2011
 



 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

e-Therapeutics plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights

X

Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

Octopus Investments Limited

4. Full name of shareholder(s)
 (if different from 3.):iv

Octopus Titan VCT 1 plc.

Octopus Titan VCT 2 plc.

Octopus Titan VCT 3 plc.

Octopus Investments Nominees Limited

Octopus Capital Limited

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

04 March 2011

6. Date on which issuer notified:

09 March 2011

7. Threshold(s) that is/are crossed or
reached:
vi, vii

5% and 6%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary shares

 

GB00B2823H99

3,138,108

3,138,108

8,768,508

8,768,508

n/a

6.4%

n/a



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

n/a

n/a

n/a

n/a

n/a


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

n/a

n/a

n/a

n/a

 

n/a

 

Nominal

Delta

n/a

n/a


Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,768,508

6.4%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

Octopus Investments Limited is the investment manager to:

Octopus Titan VCT 1 plc

Octopus Titan VCT 2 plc

Octopus Titan VCT 3 plc.

 

Octopus Investments Limited is the parent company to:

Octopus Investments Nominees Limited

 

Octopus Investments is the wholly owned fund management subsidiary of:

Octopus Capital Limited


Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will cease
to hold:

n/a

12. Date on which proxy holder will cease to hold
voting rights:

n/a



13. Additional information:



14. Contact name:

Mikko Nahkuri

15. Contact telephone number:

020 7710 2849 / 2879

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEDEFFSFEFF
UK 100

Latest directors dealings